News for McKesson Corporation (MCK.MX)

ANGEL INVESTORS. Discover how Columbus, Ohio's angel investors can fuel your startup's growth. Unlock funding and mentorship—read now!

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

On June 9, 2025, McKesson Corporation (MCK) announced updates to its Fiscal Year 2026 financial outlook during meetings with investors and analysts. The compa

McKesson Corporation (NYSE:MCK) announced that it has finalized the purchase of a majority stake in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures), a business and administrative...

McKesson Corporation acquires 70% of Core Ventures for $2.49 billion, enhancing oncology care. Partnership with Florida Cancer Specialists & Research In

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

We recently published a list of 8 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at where McKesson Corporation (NYSE:MCK) stands against other stocks that Jim Cramer discussed recently. On Wednesday’s episode of Mad Money, Jim Cramer reviewed the recent developments affecting drug distribution companies and laid […]

On May 8, 2025, McKesson Corporation announced its intention to separate its Medical-Surgical Solutions segment into an independent company.

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

McKesson Corporation (NYSE:MCK) BofA Securities 2025 Healthcare Conference May 13, 2025 11:00 AM ETCompany ParticipantsBritt Vitalone - Chief Financial...

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 2.54% (Institutional Shares) in the quarter compared to a 3.87% gain for the Russell 3000 Health Care Index (benchmark) and a 4.72% decline for the Russell […]

McKesson is a Strong Buy with growth in oncology and biopharma, 19% revenue surge, and a focus on high-growth pharma markets. Read why MCK is a Strong Buy.

Key Takeaways: McKesson Corporation (MCK) sees robust revenue growth and strong fiscal projections for 2026. Wall Street analysts provide a positive outl

The following slide deck was published by McKesson Corporation in conjunction with their 2025 Q4 earnings call.

McKesson Corporation (NYSE:MCK) Q4 2025 Earnings Conference Call May 8, 2025 4:30 PM ETCompany ParticipantsBrian Tyler - Chief Executive OfficerBritt...

McKesson Corporation (NYSE: MCK) has released its fiscal 2025 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations websit

The Board of Directors of McKesson Corporation (NYSE: MCK) yesterday declared a regular dividend of 71 cents per share of common stock. The dividend will be pa

Baron Health Care Fund retreated in the first quarter of 2025, underperforming its benchmark, the Russell 3000 Health Care Index. Read more here.